Peter G. Tombros
Peter Tombros is currently Professor and Executive in Residence in the Eberly College of Science BS/MBA Program at the Pennsylvania State University. Prior to that, he was Chairman and CEO of Vivoquest, a private biotech company which was acquired by XTL Biopharmaceuticals in September 2005. He retired from Enzon Pharma in June, 2001 after eight years as President and CEO. From 1968 to 1994, Mr. Tombros was at Pfizer Inc. where he helped to build the Pharmaceutical Business in a variety of positions including Vice President of Marketing, Senior Vice President and General Manager, Executive Vice President, Pfizer Pharmaceuticals, and Corporate Vice President for Strategic Planning.
Mr. Tombros presently serves on five public company boards including Alpharma Inc. (NYSE), Cambrex (NYSE), Dendrite International Inc. (NASDQ), Icoria (OTC Bulletin Board: ICOR.OB), and NPS Pharmaceuticals (NASDQ).
Mr. Tombros received his BS and MS degrees from Penn State and his MBA from the University of Pennsylvania Wharton School of Business.